Composition
- Active ingredients
- PIPERACILLIN SODIUM EQ 4GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PIPERACILLIN SODIUM EQ 3GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050545-003 · Discontinued
- PIPERACILLIN SODIUM EQ 40GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050545-006 · Discontinued
- PIPERACILLIN SODIUM EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050545-004 · Discontinued
- PIPERACILLIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050545-002 · Discontinued
- PIPERACILLIN SODIUM EQ 3GM BASE/VIAL · InjectableANDA062750-002 · Discontinued
- PIPERACILLIN SODIUM EQ 4GM BASE/VIAL · InjectableThis page
- PIPERACILLIN SODIUM EQ 2GM BASE/VIAL · InjectableANDA062750-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062750.
At a glance
- Brand name
- Pipracil
- Active substance
- piperacillin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Wyeth Pharms Inc
- Status
- Discontinued
- FDA approval
- 13 Oct 1987
- Application
- ANDA062750-003